September 29th at 2:00pm ET

“Strategies to advance your biologic products to the clinic with a path to commercial launch”

Walk away with a better understanding of:

• Investment in disruptive technologies to advance the manufacturing paradigm
• Structured approach to development, transfer, validation, and commercialization
• Optimization of clinical programs for robust and reliable commercial supply of bulk drug substance and drug product
• Merging technical depth with next-gen digital and regulatory capabilities for commercial supply